,
8 tweets,
2 min read
Read on Twitter
#DallasThoughts #Thread There has been a lot of talk about how the FDA has been keeping up with import inspection. The have and haven’t been doing a great job. Let me explain.
The port staff has been doing a good job keeping up but that doesn’t mean there isn’t a growing back log. The FDA is mostly (computer) automated in this area as are many other agencys.
These agencys are now experiencing computer issues that due to the #TrumpShutdown, are not being fixed (As a side note, the FDA’s systems are not any newer or being supported).
These broken systems are slowly creating a bigly growing yuuuge backlog of ships and containers waiting outside and at our ports of entry.
This slowdown is why the FDA has been keeping “pace” with inbound shipments. This slowdown though is a slow creep that will have effects for at least a year if not more across all areas of manufacturing.
As an example did you know ~90% of the ibuprofen for the world is manufactured in the US and that roughly ~70% of the API comes from China? These raw materials are not coming in on dedicated ships.
Here in lies the problem as the system as a whole slows so does all pharma manufacturing. Prices will be raised to cover these losses and you will be paying those increases.
To get back to our original statement yes the FDA is keeping up with inspections but only because the system is slowing and the FDA computers are still working ATM.
